The stock of Aurora Cannabis Inc (CVE:ACB) hit a new 52-week high and has $3.35 target or 30.00% above today’s $2.58 share price. The 6 months bullish chart indicates low risk for the $665.70 million company. The 1-year high was reported on Nov, 15 by Barchart.com. If the $3.35 price target is reached, the company will be worth $199.71M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 9.60M shares traded hands or 135.29% up from the average. Aurora Cannabis Inc (CVE:ACB) has risen 6.00% since October 16, 2016 and is uptrending. It has outperformed by 2.07% the S&P500.
More recent Aurora Cannabis Inc (CVE:ACB) news were published by: Seekingalpha.com which released: “Aurora Cannabis: Overvalued + A Misleading Management Team = SHORT” on November 08, 2016. Also Seekingalpha.com published the news titled: “Aurora Cannabis: An Execution Story” on September 16, 2016. Seekingalpha.com‘s news article titled: “Aurora Cannabis: Poised To Dominate Canadian Marijuana” with publication date: September 28, 2016 was also an interesting one.
Aurora Cannabis Inc. is engaged in the production and sale of medical cannabis. The company has a market cap of $665.70 million. The Firm is engaged in the business of producing and distributing medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations . It currently has negative earnings. The Company’s product types include Tetrahydrocannabinol (THC), Cannabidiole (CBD), indica, sativa and hybrid.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.